GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health.

OBJECTIVES To describe the grading of recommendations assessment, development and evaluation (GRADE) interactive evidence to decision (EtD) frameworks for tests and test strategies for clinical, public health, or coverage decisions. STUDY DESIGN AND SETTING As part of the GRADE Working Group's DECIDE project, we conducted workshops, user testing with systematic review authors, guideline developers and other decision makers, and piloted versions of the EtD framework. RESULTS EtD frameworks for tests share the structure, explicitness, and transparency of other EtD frameworks. They require specifying the purpose of the test, linked or related management, and the key outcomes of concern for different test results and subsequent management. The EtD criteria address test accuracy and assessments of the certainty of the additional evidence necessary for decision making. When there is no direct evidence of test effects on patient-important outcomes, formal or informal modeling is needed to estimate effects. We describe the EtD criteria based on examples developed with GRADEpro (www.gradepro.org), GRADE's software that also allows development and dissemination of interactive summary of findings tables. CONCLUSION EtD frameworks for developing recommendations and making decisions about tests lay out the sequential steps in reviewing and assessing the different types of evidence that need to be linked.

[1]  Mohit Bhandari,et al.  Patients at the centre: in our practice, and in our use of language , 2004, ACP journal club.

[2]  P. Bossuyt,et al.  Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations , 2011, Allergy.

[3]  Gordon H Guyatt,et al.  GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.

[4]  Elie A Akl,et al.  Using GRADE methodology for the development of public health guidelines for the prevention and treatment of HIV and other STIs among men who have sex with men and transgender people , 2012, BMC Public Health.

[5]  G H Guyatt,et al.  Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies , 2009, Allergy.

[6]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[7]  J André Knottnerus,et al.  Evaluation of diagnostic procedures , 2002, BMJ : British Medical Journal.

[8]  Mark Stevenson,et al.  Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. , 2006, Health technology assessment.

[9]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[10]  Paul Glasziou,et al.  Comparative accuracy: assessing new tests against existing diagnostic pathways , 2006, BMJ : British Medical Journal.

[11]  Andrew D Oxman,et al.  Transparent Development of the WHO Rapid Advice Guidelines , 2007, PLoS medicine.

[12]  Romina Brignardello-Petersen,et al.  Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise , 2014, Canadian Medical Association Journal.

[13]  Sarah E. Rosenbaum,et al.  Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results , 2013, Implementation Science.

[14]  Jan Brozek,et al.  The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity , 2015, Annals of thoracic medicine.

[15]  W. Richardson,et al.  The well-built clinical question: a key to evidence-based decisions. , 1995, ACP journal club.

[16]  J. Knottnerus The Effects of Disease Verification and Referral on the Relationship Between Symptoms and Diseases , 1987, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  David Rind,et al.  GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. , 2013, Journal of clinical epidemiology.

[18]  Enrico Compalati,et al.  Application of GRADE: Making evidence-based recommendations about diagnostic tests in clinical practice guidelines , 2011, Implementation science : IS.

[19]  Alonso Carrasco-Labra,et al.  Decision-Making about Healthcare Related Tests and Diagnostic Strategies: User Testing of GRADE Evidence Tables , 2014, PLoS ONE.

[20]  Enrico Compalati,et al.  World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines , 2010, The World Allergy Organization Journal.

[21]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[22]  Enrico Compalati,et al.  World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines , 2010, The World Allergy Organization journal.

[23]  Gordon H Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction , 2016, British Medical Journal.

[24]  C. Mulrow,et al.  Current methods of the US Preventive Services Task Force: a review of the process. , 2001, American journal of preventive medicine.

[25]  Elie A Akl,et al.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. , 2013, Journal of clinical epidemiology.

[26]  Gordon H. Guyatt,et al.  Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. , 2012, Proceedings of the American Thoracic Society.

[27]  J Kobberling,et al.  Memorandum for the evaluation of diagnostic measures. , 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[28]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[29]  Gordon H Guyatt,et al.  Uncertainties in baseline risk estimates and confidence in treatment effects , 2012, BMJ : British Medical Journal.

[30]  Keiji Fukuda,et al.  WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus , 2006, The Lancet Infectious Diseases.

[31]  Anne Eisinga,et al.  A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. , 2012, Journal of clinical epidemiology.

[32]  Wojtek Wiercioch,et al.  Decision-making about healthcare related tests and diagnostic strategies : A review of methodological and practical challenges , 2017 .

[33]  H. Schünemann,et al.  Diagnostik und linked evidence – Wie robust muss die Kette sein? , 2012 .

[34]  Gordon H Guyatt,et al.  Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[35]  G. Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines , 2016, British Medical Journal.